Items

The goal of the Strahle Lab is to understand germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH)-induced brain injury and hydrocephalus in order to develop targeted therapeutics to prevent hydrocephalus, mitigate brain injury, and improve outcomes in infants with GMH-IVH.

The Ray Lab is interested in the development and validation of electrode/tissue interfaces for regenerative and rehabilitative applications.

The Stegh Lab aims to understand and therapeutically target the genetic program that underlies the pathogenesis of glioblastoma.

Developing high-throughput technologies to study cell-cell interactions. Decoding the metastatic tumor microenvironment. Identifying therapeutic targets in cancer-stroma interactions to fight metastatic cancer.

Focusing on characterizing the function of brain circuits that control memory and arousal in normal and disease states.

Identify molecular mechanisms of neurodegeneration in Huntington’s disease.